white/抗癌药

BRIEF DESCRIPTION OF THE INVENTION The invention relates to treating neoplastic disease such as leukemia and increasing the white blood cell counts in patients suffering from neoplastic diseases or undergoing chemotherapy by a method which comprises administering parenterally to patients an

CROSS-REFERENCE TO RELATED APPLICATION The application claims the benefit under 35 U.S.C. .sctn.119 of Korean Patent Application No. 10-2008-0136873, filed Dec. 30, 2008, which is hereby incorporated by reference in its entirety. FIELD OF THE INVENTION The present invention relates to a composition

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to new hydrophobic ascorbic ester compounds, which are synthesized by linking ascorbic acid either wit monomer prostaglandin B.sub.2 or with oligomeric derivatives of prostaglandin B.sub.2, as well as to methods of

The present invention relates to a novel antibiotic F-0769, a process for its production, and its use as a growth accelerating and feed efficiency increasing agent for domestic animals or fowls and as an antitumour agent. The present inventors have isolated a number of microorganisms from various

CROSS-REFERENCE TO RELATED APPLICATION This application claims priority of U.S. provisional patent application No. 61/348,764 filed on May 27, 2010 the disclosure of which is incorporated by reference. TECHNICAL FIELD The present invention relates to a method for the preparation of a

TECHNICAL FIELD The present invention relates to a method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the composition made by the process. The present invention also relates to the use of the high-temperature stable oxygen

FIELD OF THE INVENTION This invention relates to the manufacture of novel chemical compounds which have biological activity, particularly to novel chemical compounds that are cytotoxic against colon cancer cells and colon cancer cell lines. BACKGROUND OF THE INVENTION Cancer is considered to be the

CROSS-REFERENCE TO RELATED APPLICATIONS The present application is a national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/US2012/042254 filed Jun. 13, 2012, which claims the benefit of priority of a continuation-in-part application Ser. No. 12/009,649 filed 22 Jan.

TECHNICAL FIELD The present invention relates to an agent for the treatment and/or prevention of alopecia, dandruff, white hair, and seborrheic scalp, the agent containing as an active ingredient an A-type natriuretic peptide (ANP), a B-type natriuretic peptide (BNP), a C-type natriuretic peptide

TECHNICAL FIELD The present invention relates to an agent for the treatment and/or prevention of alopecia, dandruff, white hair, and seborrheic scalp, the agent containing as an active ingredient an A-type natriuretic peptide (ANP), a B-type natriuretic peptide (BNP), a C-type natriuretic peptide

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to novel glycoproteins obtained from an extract or a supernatant of culture medium of reticulo-endothelial cells, lymphoblasts, leukemia cells or fibroblasts of warm-blooded animals, processes for their production and